Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DG4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,280
Award facts
- Contract value 100% obligated
- $25,280.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,280.06 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose-2 pens/mL, a biologic medication used to treat autoimmune and inflammatory conditions. This firm fixed price delivery order, awarded November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location, supplying the medication to support federal medical procurement needs within the military and veteran healthcare system.
This delivery order is issued under AmerisourceBergen's DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to deliver a broad spectrum of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. As one of the federal government's primary pharmaceutical vendors for the Defense Health Agency and related federal healthcare systems, AmerisourceBergen demonstrates consistent capability to fulfill specialized medical supply requirements through competitively established contract frameworks.
Quick answers
Who was awarded contract SPE2DR26F9DG4?
SPE2DR26F9DG4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9DG4 worth?
The government has obligated $25,280 on SPE2DR26F9DG4.
Is contract SPE2DR26F9DG4 an order under another contract?
Yes. SPE2DR26F9DG4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DG4 competed?
The extent of competition for SPE2DR26F9DG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award